Skip to main content
logo
Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
4.000
0.00 (0.00%)
At close: Jul 10, 2026, 4:00 PM EDT
4.010
+0.010 (0.25%)
After-hours: Jul 10, 2026, 7:14 PM EDT

Plus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.185.215.824.910.22-
Revenue Growth (YoY)
-0.46%-10.49%18.54%2093.30%--
Gross Profit
5.185.215.824.910.22-
Selling, General & Admin
14.5812.139.948.5410.246.85
Research & Development
9.498.3810.589.699.75.57
Total Operating Expenses
24.0620.5120.5218.2319.9412.43
Operating Income
-18.88-15.3-14.7-13.32-19.71-12.43
Interest Income
0.310.120.270.40.150.02
Interest Expense
0.13-3.61-3.72-0.4-0.71-0.93
Other Non-Operating Income (Expense)
7.47-3.65.17-0-0.06
Total Non-Operating Income (Expense)
7.91-7.091.720.01-0.56-0.97
Pretax Income
-10.97-22.39-12.98-13.32-20.28-13.4
Net Income
-10.97-22.39-12.98-13.32-20.28-13.4
Net Income to Common
-10.97-22.39-12.98-13.32-20.28-13.4
Shares Outstanding (Basic)
430000
Shares Outstanding (Diluted)
630000
Shares Change (YoY)
1566.98%910.35%145.18%79.45%117.18%173.03%
EPS (Basic)
-1.55-7.25-48.75-106.00-289.50-415.75
EPS (Diluted)
-2.30-7.25-58.50-106.00-289.50-415.75
Free Cash Flow
-21.72-20.84-10.7-12.85-12.97-13.01
Free Cash Flow Per Share
-3.37-6.70-34.74-102.29-185.28-403.60
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-364.36%-293.46%-252.32%-271.14%-8800.00%-
Profit Margin
-211.71%-429.43%-222.84%-271.04%-9051.34%-
FCF Margin
-419.20%-399.81%-183.72%-261.57%-5791.07%-
EBITDA
-18.49-14.85-13.82-12.69-19.09-11.8
EBITDA Margin
-356.73%-284.92%-237.34%-258.35%-8523.66%-
EBIT
-18.88-15.3-14.7-13.32-19.71-12.43
EBIT Margin
-364.36%-293.46%-252.32%-271.14%-8800.00%-
SEC Filings: 10-K · 10-Q